Comparison between Antony Waste Handling Cell IPO and Gland Pharma IPO.
Antony Waste Handling Cell IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Gland Pharma IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Antony Waste Handling Cell IPO is up to ₹299.99 Cr whereas the issue size of the Gland Pharma IPO is up to ₹6,479.55 Cr. The final issue price of Antony Waste Handling Cell IPO is ₹315.00 per share and of Gland Pharma IPO is ₹1,500.00 per share.
| Antony Waste Handling Cell IPO | Gland Pharma IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹1 per share |
| Issue Price (Lower) | ₹313.00 per share | ₹1,490.00 per share |
| Issue Price (Upper) | ₹315.00 per share | ₹1,500.00 per share |
| Issue Price (Final) | ₹315.00 per share | ₹1,500.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 47 shares | 10 shares |
| Fresh Issue Size | 26,98,412 shares | 83,33,333 shares |
| Fresh Issue Size (Amount) | up to ₹85.00 Cr | up to ₹1,250.00 Cr |
| OFS Issue Size | 68,24,933 shares | 3,48,63,635 shares |
| OFS Issue Size (Amount) | up to ₹214.99 Cr | up to ₹5,229.55 Cr |
| Issue Size Total | 95,23,345 shares | 4,31,96,968 shares |
| Issue Size Total (Amount) | up to ₹299.99 Cr | up to ₹6,479.55 Cr |
Antony Waste Handling Cell IPO opens on Dec 21, 2020, while Gland Pharma IPO opens on Nov 09, 2020. The closing date of Antony Waste Handling Cell IPO and Gland Pharma IPO is Dec 23, 2020, and Nov 11, 2020, respectively.
| Antony Waste Handling Cell IPO | Gland Pharma IPO | |
|---|---|---|
| Anchor Bid Date | Dec 18, 2020 | Nov 06, 2020 |
| Issue Open | Dec 21, 2020 | Nov 09, 2020 |
| Issue Close | Dec 23, 2020 | Nov 11, 2020 |
| Basis Of Allotment (Tentative) | Dec 29, 2020 | Nov 17, 2020 |
| Initiation of Refunds (Tentative) | Dec 30, 2020 | Nov 18, 2020 |
| Credit of Share (Tentative) | Dec 31, 2020 | Nov 19, 2020 |
| Listing date (Tentative) | Jan 01, 2021 | Nov 20, 2020 |
| Anchor Lockin End date 1 | Jan 28, 2021 | Dec 17, 2020 |
| Anchor Lockin End date 2 | Mar 29, 2021 | Feb 15, 2021 |
Antony Waste Handling Cell IPO P/E ratio is , as compared to Gland Pharma IPO P/E ratio of .
| Antony Waste Handling Cell IPO | Gland Pharma IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 51.10 | 74 | ||||
| Promoter Shareholding (Post-Issue) | 46.20 | 58 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹891.05 Cr. | ₹24492.42 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Antony Waste Handling Cell IPO Retail Individual Investors (RII) are offered 33,33,171 shares while in Gland Pharma IPO retail investors are offered 33,33,171 shares. Qualified Institutional Buyers (QIB) are offered 19,04,669 shares in Antony Waste Handling Cell IPO and 86,39,394 shares in Gland Pharma IPO.
| Antony Waste Handling Cell IPO | Gland Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 28,57,003 shares | 1,29,59,089 shares |
| Market Maker Reservation | ||
| QIB | 19,04,669 shares | 86,39,394 shares |
| NII | 14,28,502 shares | 64,79,546 shares |
| RII | 33,33,171 shares | 1,51,18,939 shares |
| Employee | ||
| Others | ||
| Total | 95,23,345 shares | 4,31,96,968 shares |
Antony Waste Handling Cell IPO subscribed 15.04x in total, whereas Gland Pharma IPO subscribed 2.06x.
| Antony Waste Handling Cell IPO | Gland Pharma IPO | |
|---|---|---|
| QIB (times) | 9.67x | 6.40x |
| NII (times) | 18.69x | 0.51x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 16.55x | 0.24x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 15.04x | 2.06x |
